Literature DB >> 17319991

Is simultaneous bilateral mastoidectomy ever advisable?

J J Klemens1, E Mhoon, M Redleaf.   

Abstract

INTRODUCTION: We report our experience with bilateral, simultaneous tympanomastoidectomies and the results of an opinion survey of otologists.
METHODS: A chart review of 116 tympanomastoidectomies revealed 12 patients who underwent bilateral, simultaneous tympanomastoidectomies. An opinion survey generated 121 responses.
RESULTS: Of the 12 patients, none suffered any outcome which would have been avoided by staging the procedures. Twenty-three of 24 operated ears had the same or better hearing post-operatively. Of the survey respondents, 74 felt that performing bilateral, simultaneous tympanomastoidectomies was unsafe, largely because of the risk of bilateral sensorineural hearing loss. DISCUSSION: Although bilateral, simultaneous tympanomastoidectomies carry double the risk of unilateral sensorineural hearing loss, compared with the unilateral procedure, the risk of bilateral sensorineural hearing loss is only 0.006-0.2 per cent, as derived mathematically from historical data. Respondents to the survey were mostly opposed to bilateral, simultaneous tympanomastoidectomies, but even those opposed gave indications for simultaneous procedures. This finding probably reflects an ambivalence about the theoretical risks of the operation versus the potential patient benefits. A decision tree for proceeding to the second case is presented.

Entities:  

Mesh:

Year:  2007        PMID: 17319991     DOI: 10.1017/S0022215107006330

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

1.  Comparison of sequential same-day middle ear surgeries: bilateral mastoidectomy, unilateral mastoidectomy with contralateral tympanoplasty, and bilateral tympanoplasty.

Authors:  Chang Woo Kim; Joong Seob Lee; Chan Hum Park; Sae Young Kwon; Dong-Kyu Kim; Jun Ho Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-27       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.